(R)-3-(Cyclopentylmethyl)-4-((S)-6-(3-(4-fluoro-2-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)-5-azaspiro[2.4]-heptan-5-yl)-N-hydroxy-4-oxobutanamide

ID: ALA4635911

Chembl Id: CHEMBL4635911

PubChem CID: 156014220

Max Phase: Preclinical

Molecular Formula: C25H28F4N4O4

Molecular Weight: 524.52

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(C[C@@H](CC1CCCC1)C(=O)N1CC2(CC2)C[C@H]1c1nc(-c2ccc(F)cc2C(F)(F)F)no1)NO

Standard InChI:  InChI=1S/C25H28F4N4O4/c26-16-5-6-17(18(11-16)25(27,28)29)21-30-22(37-32-21)19-12-24(7-8-24)13-33(19)23(35)15(10-20(34)31-36)9-14-3-1-2-4-14/h5-6,11,14-15,19,36H,1-4,7-10,12-13H2,(H,31,34)/t15-,19+/m1/s1

Standard InChI Key:  QJELKHPYTGUQHI-BEFAXECRSA-N

Alternative Forms

  1. Parent:

    ALA4635911

    ---

Associated Targets(Human)

PDF Tchem Peptide deformylase mitochondrial (169 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SJSA-1 (970 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF-10A (2462 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HDAC1 Tclin Histone deacetylase 1 (10854 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HDAC6 Tclin Histone deacetylase 6 (20808 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 524.52Molecular Weight (Monoisotopic): 524.2047AlogP: 5.04#Rotatable Bonds: 7
Polar Surface Area: 108.56Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 8.90CX Basic pKa: 0.41CX LogP: 4.41CX LogD: 4.40
Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.30Np Likeness Score: -0.57

References

1. Hu L, Cai X, Dong S, Zhen Y, Hu J, Wang S, Jiang J, Huang J, Han Y, Qian Y, Yuan Y, Hu W..  (2020)  Synthesis and Anticancer Activity of Novel Actinonin Derivatives as HsPDF Inhibitors.,  63  (13): [PMID:32551649] [10.1021/acs.jmedchem.0c00079]

Source